Cargando…
A novel anti-NGF PEGylated Fab’ provides analgesia with lower risk of adverse effects
Nerve growth factor (NGF) has emerged as a key driver of pain perception in several chronic pain conditions, including osteoarthritis (OA), and plays an important role in the generation and survival of neurons. Although anti-NGF antibodies improve pain control and physical function in patients with...
Autores principales: | Koya, Yukari, Tanaka, Hirotsugu, Yoshimi, Eiji, Takeshita, Nobuaki, Morita, Shuji, Morio, Hiroki, Mori, Kanako, Fushiki, Hiroshi, Kamohara, Masazumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721442/ https://www.ncbi.nlm.nih.gov/pubmed/36458900 http://dx.doi.org/10.1080/19420862.2022.2149055 |
Ejemplares similares
-
An engineered tetra-valent antibody fully activates the Tie2 receptor with comparable potency to its natural ligand angiopoietin-1
por: Koya, Yukari, et al.
Publicado: (2021) -
Preclinical evaluation of topically-administered PEGylated Fab’ lung toxicity
por: Freches, Danielle, et al.
Publicado: (2019) -
Evaluation of FGFR inhibitor ASP5878 as a drug candidate for achondroplasia
por: Ozaki, Tomonori, et al.
Publicado: (2020) -
Single chain Fab (scFab) fragment
por: Hust, Michael, et al.
Publicado: (2007) -
Production of single chain Fab (scFab) fragments in Bacillus megaterium
por: Jordan, Eva, et al.
Publicado: (2007)